Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 781

1.

In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.

Siemasko KF, Gao J, Calder VL, Hanna R, Calonge M, Pflugfelder SC, Niederkorn JY, Stern ME.

Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5434-40. doi: 10.1167/iovs.08-2075.

PMID:
18658093
2.
3.
4.

Frequency of Foxp3+CD4CD25+ T cells is associated with the phenotypes of allergic asthma.

Matsumoto K, Inoue H, Fukuyama S, Kan-O K, Eguchi-Tsuda M, Matsumoto T, Moriwaki A, Nakano T, Nakanishi Y.

Respirology. 2009 Mar;14(2):187-94. doi: 10.1111/j.1440-1843.2008.01472.x.

PMID:
19192224
5.

[Changes of regulatory T cell number in hepatocellular carcinoma-bearing mice and its relationship with tumor growth].

Zhang P, Zhang LN, Zhu FL, Wang Q, Wang XY, Li HY, Liu CM, Gao F, Liu CH.

Zhonghua Zhong Liu Za Zhi. 2007 May;29(5):342-5. Chinese.

PMID:
17892128
6.

Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.

Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.

Exp Hematol. 2007 Mar;35(3):416-25.

PMID:
17309822
7.

Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.

He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.

Surgery. 2009 Jun;145(6):663-74. doi: 10.1016/j.surg.2009.01.016.

PMID:
19486771
8.

In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.

Tsang J, Jiang S, Tanriver Y, Leung E, Lombardi G, Lechler RI.

Int Immunopharmacol. 2006 Dec 20;6(13-14):1883-8.

PMID:
17161341
9.

Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.

Sun M, Yang P, Du L, Zhou H, Ren X, Kijlstra A.

Invest Ophthalmol Vis Sci. 2010 Jan;51(1):383-9. doi: 10.1167/iovs.09-3514.

PMID:
19696173
10.

Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.

Keino H, Takeuchi M, Kezuka T, Hattori T, Usui M, Taguchi O, Streilein JW, Stein-Streilein J.

Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1047-55.

PMID:
16505040
11.

CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.

Siepmann K, Biester S, Plsková J, Muckersie E, Duncan L, Forrester JV.

Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):221-9.

PMID:
16741709
12.

TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.

Pyzik M, Piccirillo CA.

J Leukoc Biol. 2007 Aug;82(2):335-46.

PMID:
17475784
13.

[Effect of Rapamycin on CD4(+) CD25(+) regulatory T cells in allo-transplantation tolerance model].

Zheng YX, Hou GH, Song J, Zhang C, Liang T.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Apr;23(4):327-30. Chinese.

PMID:
17428387
14.

Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.

Bank U, Tadje J, Täger M, Wolke C, Bukowska A, Ittenson A, Reinhold D, Helmuth M, Ansorge S, Shakespeare A, Vieth M, Malfertheiner P, Naumann M, Lendeckel U.

Int J Mol Med. 2007 Oct;20(4):483-92.

PMID:
17786278
15.

Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts.

Xia G, He J, Leventhal JR.

Am J Transplant. 2008 Feb;8(2):298-306. doi: 10.1111/j.1600-6143.2007.02088.x.

16.

Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.

Knol AC, Lemaître F, Pandolfino MC, Volteau C, Quéreux G, Saiagh S, Khammari A, Viguier M, Dréno B.

Exp Dermatol. 2008 May;17(5):436-45. doi: 10.1111/j.1600-0625.2007.00681.x.

PMID:
18312383
17.

The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.

Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C, Zhao Y.

Transpl Immunol. 2007 Apr;17(3):153-61.

PMID:
17331841
18.

Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.

Su H, Ye DQ, Wang BL, Fang XH, Chen J, Wang Q, Li WX, Zhang N.

Br J Dermatol. 2008 Jun;158(6):1197-209. doi: 10.1111/j.1365-2133.2008.08555.x.

PMID:
18410422
19.

Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.

Yu QT, Saruta M, Avanesyan A, Fleshner PR, Banham AH, Papadakis KA.

Inflamm Bowel Dis. 2007 Feb;13(2):191-9.

PMID:
17206665
20.
Items per page

Supplemental Content

Support Center